Search - tctmd.com

Displaying 481 - 500 of 654

Sort: Relevancy | Date

Presentation TCT 2015

Updates From the PARTNER Trials 2: Reports From Selected Substudies

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Darshan Doshi

October 11, 2015

Presentation TCT 2015

Updates From the PARTNER Trials 1: Follow-up From the Inoperable and High-Risk Subgroups

Presenter: Samir R. Kapadia, Jeffrey J. Popma

October 11, 2015

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

Presenter: Martin B. Leon, Neil E. Moat

October 11, 2015

Presentation TCT 2015

NSTE-ACS Case Presentation: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

STEMI Case Presentation With MVD: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Sreenivas Arramraju Kumar

October 11, 2015

Presentation TCT 2015

Complex PCI Case Presentation: Indications to Treatment

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu

October 11, 2015

Presentation TCT 2015

Special Lecture: Retrograde CTO PCI From Inception to Current Practice

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Lei Ge

October 11, 2015

Presentation

Temporal Trends in QoL Outcomes After Transapical TAVR: PARTNER Substudy

Presenter: H. Gada

June 12, 2015

Presentation TVT 2015

PARTNER 5-Year Follow-up

Presenter: Martin B. Leon

June 05, 2015

Presentation TVT 2015

The Association of Paravalvular Regurgitation After TAVR and Subsequent Mortality: Comprehensive Review of the Literature and Observations From PARTNER and US CoreValve Trials

Presenter: Jeffrey J. Popma, John G. Webb, Susheel K. Kodali

June 05, 2015

Presentation TVT 2015

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Presenter: Raj Makkar, Mathew Williams, Vasilis Babaliaros

June 04, 2015

Presentation ACC 2015

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Presenter: Michael J. Mack

March 15, 2015

Presentation

PARTNER: Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Presenter: T.M. Nazif

January 19, 2015

Presentation

Outcomes After Transfemoral TAVR: Comparison of the PARTNER Trial With the NRCA Registry

Presenter: WF Fearon

November 24, 2014

Presentation

PARTNER Substudy: Impact of Aortic Annulus Size on Valve Hemodynamics, Clinical Outcomes

Presenter: Josep Rod?s-Cabau

October 09, 2014

Presentation

Paravalvular Regurgitation after TAVR with the Edwards Sapien Valve in the PARTNER Trial

Presenter: Susheel Kodali

October 08, 2014

Presentation TCT 2014

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

Presenter: James B. Hermiller Jr, Susheel Kodali, Augusto D. Pichard, Alan Zajarias

September 16, 2014

Presentation TCT 2014

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

Presenter: Philippe Pibarot, Allan Schwartz, Gary Gershony, Josep Rodés-Cabau

September 16, 2014

Presentation TCT 2014

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Presenter: Thomas F. Luscher, Danny Dvir

September 16, 2014

Presentation TCT 2014

Priming Innovation: The Right Environment, Tools, Partners, and Mentors

Presenter: Chaim S. Lotan, Paul G. Yock, Louis A. Cannon, Paul A. Iaizzo

September 14, 2014

Advertisement

Updates From the PARTNER Trials 2: Reports From Selected Substudies

Updates From the PARTNER Trials 1: Follow-up From the Inoperable and High-Risk Subgroups

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

NSTE-ACS Case Presentation: From Presentation Through Discharge

STEMI Case Presentation With MVD: From Presentation Through Discharge

Complex PCI Case Presentation: Indications to Treatment

Special Lecture: Retrograde CTO PCI From Inception to Current Practice

Temporal Trends in QoL Outcomes After Transapical TAVR: PARTNER Substudy

PARTNER 5-Year Follow-up

The Association of Paravalvular Regurgitation After TAVR and Subsequent Mortality: Comprehensive Review of the Literature and Observations From PARTNER and US CoreValve Trials

Transapical vs Direct Aortic TAVR: Lessons From the PARTNER Trial

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

PARTNER: Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After TAVR

Outcomes After Transfemoral TAVR: Comparison of the PARTNER Trial With the NRCA Registry

PARTNER Substudy: Impact of Aortic Annulus Size on Valve Hemodynamics, Clinical Outcomes

Paravalvular Regurgitation after TAVR with the Edwards Sapien Valve in the PARTNER Trial

TCT 699: The Effect of Tricuspid Regurgitation and Right Ventricular Dysfunction on Mortality in High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER II Inoperable Cohort

TCT 697: Is Transcatheter Aortic Valve Replacement the Best Option for Patients with Severe Aortic Stenosis and Small Aortic Annulus? Insights from the PARTNER Trial

TCT 693: Influence of Body Mass Index on Survival of Aortic Stenosis Patients Treated by Transcatheter Aortic Valve Replacement: Insights on the Obesity Paradox from the PARTNER Trial

Priming Innovation: The Right Environment, Tools, Partners, and Mentors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content